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Abstract
Objective: While respiratory symptoms in the first year
of life are relatively well described for term infants,
data for preterm infants are scarce. We aimed to de-
scribe the burden of respiratory disease in a group of
preterm infants with and without bronchopulmonary
dysplasia (BPd) and to assess the association of respi-
ratory symptoms with perinatal, genetic and environ-
mental risk factors.
Methods: single centre birth cohort study: prospective
recording  of  perinatal  risk  factors  and  retrospective
assessment of respiratory symptoms during the first
year of life by standardised questionnaires. Main out-
come measures: Cough and wheeze (common symp-
toms), re-hospitalisation and need for inhalation thera-
py (severe outcomes). Patients: 126 preterms (median
gestational age 28.7 weeks; 78 with, 48 without BPd)
hospitalised  at  the  university  Children’s  Hospital  of
Bern, switzerland 1999-2006.
Results: Cough occurred in 80%, wheeze in 44%, re-
hospitalisation in 25% and long term inhalation thera-
py in wheezers in 13% of the preterm infants. using
logistic regression, the main risk factor for common
symptoms was frequent contact with other children.
severe outcomes were associated with maximal peak
inspiratory pressure, arterial cord blood pH, aPGaR-
and CRIB-score.
Conclusions: Cough in preterm infants is as common
as in term infants, whereas wheeze, inhalation therapy
and re-hospitalisations occur more often. severe out-
comes  are  associated  with  perinatal  risk  factors.
Preterm infants who did not qualify for BPd accord-
ing to latest guidelines also showed a significant bur-
den of respiratory disease in the first year of life. 
Key  words: premature birth, cough, wheeze, risk fac-
tors, bronchopulmonary dysplasia.
IntRoduCtIon
Respiratory problems are major consequences of pre-
maturity, however the heterogeneity of respiratory se-
quelae and varying definitions have made a systematic
assessment  difficult.  northway  et  al.  were  the  first 
to  describe  them  as  “bronchopulmonary  dysplasia”
(BPd) [1]. the definition of BPd has been revised
several times as with advances in perinatal treatment
the  clinical  and  pathomorphological  patterns  have
changed.  the  most  recent  consensus  definition  of
2001 groups severity of “new BPd” into mild, moder-
ate and severe according to gestational age and dura-
tion  of  supplementary  oxygen  [2].  Recently  a  large
american cohort study used this definition to assess
its usefulness for predicting respiratory morbidity in
the first year of life [3]. the authors found a high sen-
sitivity  using  this  BPd  classification,  but  specificity
was poor: 30% of preterm infants had severe respira-
tory problems without qualifying for BPd. since in-
formation on additional risk factors is lacking, it re-
mains unclear whether the identification of risk fac-
tors  could  help  improving  prediction  of  respiratory
morbidity after preterm birth. 
Incidence and severity of respiratory symptoms in
the  first  year  of  life  are  relatively  well  described  in
term  born  infants.  one  study  reported  persistent
cough to occur in 56% and wheeze in 45% of term-
born infants in the usa [4]. another study, conducted
in australia, found 77% of the infants coughing and
27% wheezing during the first year of life [5]. In a re-
cent prospective study from our group assessing respi-
ratory morbidity in a birth cohort of term-born in-
fants, any cough occurred in 93% and wheeze in 21%
of the infants during the first year of life [6]. frequen-
cy of symptoms was associated with male sex, higher
birthweight, pre- and postnatal smoke exposure and
day care or older siblings. only 3 of all 195 infants
(1.5%) had to be hospitalised for respiratory problems
in their first year of life [6]. 
In contrast to term infants, few data are available on
respiratory  morbidity  in  preterm  infants.  there  are
studies on outcome and associated risk factors from
the pre-surfactant era [7], but data including children
with  the  “new”  form  of  BPd  are  scarce.  Most  of
these studies focused on severe outcomes [3] and only
few have determined risk factors [8] for pulmonary se-
quelae for which preterm infants show a predisposi-
tion [9-11]. 
the aim of the present study was to describe fre-
quency and spectrum of respiratory symptoms during
the first year of life in a contemporary population of
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5) Pramana_Umbruchvorlage  21.04.11  15:25  Seite 223preterm infants with and without BPd and to identify
environmental  and  perinatal  risk  factors  associated
with common and severe respiratory symptoms.
MEtHods
study dEsIGn
Preterm infants (gestational age <37 wks), born be-
tween July 1999 and June 2005 and hospitalised at the
universityHospitalof Bern,switzerland,were prospec-
tively recruited during a consultation of a paediatric
pulmonologist  before  discharge.  Perinatal  data  were
routinely recorded using the institutional neonatology
database (nEodat 4.10, t￼bingen, Germany). after
the first year of life, a standardised questionnaire was
sent to the parents to assess respiratory morbidity dur-
ing the first year after discharge and ongoing environ-
mental exposures. 
suBJECts
We approached preterm infants independent of their
birthweight  with  168  being  recruited  for  the  study.
More parents of infants with lower birthweight agreed
to participate resulting in a study population of 123
(72%), 67 (40 %) and 3 (2%)  preterms with birth-
weights below 1500g,  below 1000g and below 500g,
respectively. 
Based  on  the  ats  definition  of  BPd,  we  cate-
gorised preterm infants into healthy, mild, moderate
and severe BPd, respectively [2]. BPd was defined as
supplemental oxygen requirement for at least 28 days.
time point of assessment for BPd severity was at 36
weeks  post-menstrual  age  (PMa)  or  at  discharge
(whichever occurred first) in infants born at less than
32 weeks of gestation, and at day 56 of life in infants
born with at least 32 weeks of gestation. Mild BPd
was defined as breathing room air, moderate BPd as
requiring less than 30% supplemental oxygen and se-
vere BPd as the need for more than 30% of oxygen.
the standardised internal hospital guidelines were ap-
plied to determine the exact amount of oxygen need-
ed (aiming for 92% or more oxygen saturation allow-
ing dips to 86%) and BPd classification was verified
in each case by review of the medical records. the
ethics committee of the canton of Bern approved the
study protocol and written informed consent was ob-
tained from the parents.
assEssMEnt of PERInataL data
the data routinely entered in the institutional database
(nEodat) are given in table 1 and 3.
dEfInItIon of REsPIRatoRy MoRBIdIty
(outCoMEs) 
Respiratory morbidity was assessed by a standardised
questionnaire using modified questions from the In-
ternational study on asthma and allergies in Child-
hood (IsaaC) [12, 13] to the parents. the main out-
comes  were  categorised  into  common  and  severe:
Cough with cold (“did your child cough during times
with a cold?”) and wheeze were considered as com-
mon respiratory symptoms, whereas re-hospitalisation
for pulmonary reasons (excluding readmissions for di-
agnostic  purposes)  or  long-term  inhalation  therapy
(longer than four weeks) in wheezing infants were de-
fined as severe outcomes [3, 14]. In addition the sub-
jective burden of disease and the need for consulta-
tions at any healthcare institution were assessed by the
questionnaire. 
dEfInItIon of RIsK faCtoRs
Potential risk factors were grouped into 3 categories: 
a) Perinatal risk factors: factors that have previous-
ly been described as either influencing the outcome of
preterm infants or having an effect on the occurrence
of BPd such as gestational age, sex, birthweight, ma-
ternal  chorioamnionitis  (histopathologically  con-
firmed), Pda (patent ductus arteriosus) when of he-
modynamic relevance in echocardiography, peak inspi-
ratory  pressure  (PIP)  during  mechanical  ventilation
and antenatal steroids [15-18].
B) factors of postnatal adaptation: Perinatal para-
meters reflecting the adaptation and initial condition
of the newborn, such as aPGaR score, arterial cord-
blood pH-value [19] and CRIB score. 
C)  Environmental  and  sociodemographic  expo-
sures: Known risk factors for respiratory symptoms in
term infants including day care or older siblings, histo-
ry of parental atopic disease and smoke exposure [6,
20]. 
statIstICaL anaLysIs
We used descriptive statistics to illustrate the occur-
rence and parental perception of respiratory morbidi-
ty.  second,  to  identify  possible  risk  factors,  we
grouped all outcome parameters into binary categories
and calculated the association between outcomes and
risk factors using logistic regression analysis. all listed
risk factors were entered into the model one by one as
explanatory  factors;  continuous  variables  were  cen-
tred. Results are given as odds ratios with confidence
intervals and exact p-values. due to the small sample
size and a strong co-linearity between many of the pa-
rameters,  only  univariable  analysis  was  performed.
sensitivity analysis stratifying for gestational age, sex,
birthweight  and  age  at  reply  of  questionnaire  con-
firmed the main results. data analyses were performed
using  stataﾮ  version  8.2  for  Windows  (stata
Corporation, College station, tX, usa).
REsuLts
suBJECts
We primarily recruited 168 infants and received 126
(75%) completed questionnaires back. Median gesta-
tional age was 28.7 weeks (range 23.9-36.1), median
birthweight was 1070g (range 420-2980), 71 (56%) in-
fants were male and 55 (44%) female; 78 (62%) ful-
filled the criteria of new BPd and 48 (38%) were clas-
sified as having no BPd. 
of all questionnaires, 65% were filled in by the par-
ents  when  their  child  was  1-3  years,  35%  when  the
child was older. a sensitivity analysis showed no dif-
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of the study group are given in table 1.
BuRdEn of REsPIRatoRy MoRBIdIty
the  occurrence  of  common  respiratory  symptoms
(e.g. cough and wheeze) and severe outcomes (e.g. re-
hospitalisation  and  long  term  inhalation  therapy)  is
shown in table 2, burden of disease is illustrated in
figure1.Common respiratory symptoms occurred with
high frequency: 80% (95%-CI 71-86%) of the infants
had cough and 44% (95%-CI 36-54%) wheeze.
severe outcomes were less frequent: re-hospitalisa-
tion  occurred  in  25%  (95%-CI  17-33%)  of  all  chil-
dren, and long term inhalation because of wheezing in
13% (95%-CI 7-20%) of the infants. Parental state-
ment  of  re-hospitalisation  was  very  consistent  with
medical records.
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Table 2. Respiratory outcome in the first year after discharge.
total no BPD BPD
BPD vs
no BPD
Variables n = 126 n = 48 n = 78
abs % CI % abs % CI % abs % CI % p-value
Common outcomes
Cough 100 79 71 - 86 40 83 70 - 93 60 77 66 - 86 0.50
Wheezinga 56 44 36 - 54 23 48 33 - 63 33 43 31 - 54 0.58
Severe outcomes
Re-hospitalisationb 31 25 17 - 33 11 23 12 - 37 20 26 16 - 37 0.83
Inhalation therapyc 16 13 7 - 20 361 - 17 13 17 9 - 27 0.25
numbers are given as absolute count (abs) as well as percentage and 95% Confidence interval (CI).
adata not available for 2 infants
bRehospitalisation for respiratory reasons (excluding admissions for diagnostic purposes)
cInhalation therapy because of prolonged wheezing with corticosteroids, beta-mimetika or both, for more than four weeks.
Table 1. Characteristics of the study population of preterm infants (n = 126).
Characteristics n  % a
Bronchopulmonary dysplasia (BPd) 78  62
mild BPd  28 36
moderate BPd  36 46
severe BPd  14 18
Gestational age in weeks (median/range) 28.71 23.9 - 36.1
Male sex 71 56
Birthweight in g (median/range) 1070 420-2980
Chorioamnionitis  42 37
Patent ductus arteriosus 29 23
Prenatal steroids 102 81
surfactant therapy 48 38
Mechanical ventilation  66 52
days of mech. ventilation (median/range)  1 0-63
CPaP b 113 90
days on oxygen therapy (median/range) 42 0-385
days of initial hospital stay (median/range) 70 7-141
Contact to other children c 75 61
Maternal smoking in pregnancy d 13 10
Maternal atopy e 20 16
a data are given as number (percentage) if not indicated otherwise.
b CPaP = continuous positive airway pressure breathing support
c Contact to other children = having siblings or going to a nursery care institution regularly 
d assessed by parental questionnaire
e Maternal atopy = mother has asthma and/or allergic rhinitis and/or atopic dermatitis
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fer between children with and without BPd, there was
a trend towards more inhalation therapy in the BPd
group.
of the patients included 9 (7%)  had RsV vaccina-
tion; 8 (6%) children suffered from severe RsV infec-
tion they needed to be hospitalised for, two of those
had been vaccinated before.
PaREntaL PERCEPtIon of REsPIRatoRy MoRBIdIty
In 53 families (45%) parents considered their infant to
cough as much as a healthy term infant, 34 (29%) be-
lieved their infant to cough more often and 30 (26%)
less often than healthy infants. 
slightly more than half of the parents (n=65, 55%)
reported that they consulted the community paediatri-
cian in an emergency situation during the first year of
life, 43 (73%) of those once or twice and 16 (27%)
more often, up to a maximum of 10 times. 
dEtERMInants of REsPIRatoRy outCoME
table 3 shows associations between analysed risk fac-
tors and respiratory morbidity. 
Common symptoms
Common respiratory symptoms were mainly associat-
ed with environmental exposures. Children who were
exposed to other children had a four-fold risk of hav-
ing  common  symptoms  (oR  4.7;  95%-CI  1.8-12.6,
p=0.002). While there was no difference between the
outcomes cough and wheeze for most of the risk fac-
tors, maternal smoking during pregnancy was associat-
ed mainly with wheeze (oR 4.7; 95%-CI 1.2-18.1, p =
0.024)  and  contact  with  other  children  mainly  with
cough in the first year of life (oR 4.1; 95%-CI 1.6-
10.5, p=0.004).
Severe outcomes
Contrary to those for common symptoms, risk factors
for  severe  outcomes  were  mainly  parameters  repre-
senting perinatal adaptation. a significant association
with  both  re-hospitalisation  and  inhalation  therapy
was found for high peak inspiratory pressure, low arte-
rial cord blood pH, low aPGaR-score and low CRIB-
score, as shown in table 3. Low arterial cord blood
pH  (<7.15)  was  associated  with  a  4.4-fold  (95%-CI
1.4-13.6,  p=0.011)  increased  likelihood  of  severe
symptoms.
no association was found between any of the in-
vestigated outcomes and need for intubation, surfac-
tant  therapy,  parental  educational  status  or  parental
smoking in the first year. 
dIsCussIon
suMMaRy
In  our  cohort  of  preterm  infants  with  and  without
BPd, respiratory symptoms were frequent during in-
fancy:  cough  with  cold  was  reported  for  80%  and
wheeze for 45% of infants, respectively. More severe
symptoms were less common, with re-hospitalisation
for  respiratory  reasons  occurring  in  25%  of  infants
and 13% of infants needing long-term inhalation ther-
apy of more than four weeks because of wheezing.
Risk factors differed between common and severe
symptoms. While common symptoms were associated
with environmental factors such as contact to other
children, severe symptoms were associated with risk
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Fig.  1.  Burden  of  common  and  severe
symptoms in pretem (n = 126) and term
(n = 195).
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score, CRIB-score and cord blood pH.
REsPIRatoRy MoRBIdIty
data on prevalence of cough and wheeze in preterm
infants  from  the  post-surfactant  era  are  rare:  Gree-
nough  et  al.  reported  that  51%  of  preterm  infants
born at less than 29 weeks of gestation suffered from
cough and 42% from wheeze during the first year of
life  [8].  Vrijland  et  al.  described  cough  to  occur  in
97% and wheeze in 39% of preterm infants [21]. In
an important study from the presurfactant era 53 to
65% of the infants had cough or wheeze during the
first 6 months of life [22]. our results are well in line
with these reports. Interestingly, despite differences in
data assessment, age range, observational periods and
countries,  the  high  prevalence  of  wheeze  and  even
higher prevalence of cough seems to be a consistent
finding among studies.
Re-hospitalisation  rates  of  preterm  infants  in  the
first 1-2 years are reported in the literature to occur in
14%  [23]  to  38%  [24]  of  preterm  infants  with  and
without  BPd,  well  comparable  to  our  results  and
known to be dependent on gestational age and differ-
ences in patient management [24]. 
to our knowledge there are no data available com-
paring  respiratory  morbidity  between  term-  and
preterm-born infants from the same area and time pe-
riod. We have recently reported on respiratory morbid-
ity and risk factors in a large unselected prospective co-
hort of term-born infants with weekly assessment of
respiratory symptoms [6]. Recruitment area and time
period were the same as in the present study. In these
healthy  term-born  infants,  the  overall  prevalence  of
cough  was  comparable  (93%,  compared  to  79%  in
preterm children), whereas wheeze occurred less often
in term children (21%) than in preterm children (44%).
this is quite remarkable, considering that the method
of data collection used for term infants (weekly phone
calls) is expected to be more sensitive than the method
used for preterm children (retrospective questionnaire)
[12]. Hospitalisation due to respiratory reasons in the
first year of life was reported for 25% of preterm, but
only for 1.5% of term-born infants [6].
RIsK faCtoRs
Common  symptoms  were  mainly  associated  with 
environmental exposures, in accordance with findings
by  Greenough  et  al.  who  reported  that  male  sex, 
duration of oxygen therapy, older siblings and socioe-
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Table 3. Risk factors and their association with common and severe respiratory outcomes  in all subjects (n = 126).
Risk factors Common outcomes Severe outcomes
n = 101 n = 37
OR CI p-value OR CI p-value
BPda 0.57  (0.22-1.49)  0.249 1.20  (0.54-2.66)  0.659
Known risk factors for BPD
Gestational age, per week 1.04  (0.89-1.22)  0.605 0.94  (0.82-1.08)  0.375
Male sex 1.25  (0.52-3.00)  0.625 1.02  (0.47-2.22)  0.953
Birthweight, per kg 1.36  (0.56-3.29)  0.493 0.70  (0.32-1.51)  0.362
Chorioamnionitisb 1.58  (0.56-4.44)  0.387 1.55  (0.68-3.52)  0.295
Pdac 1.65  (0.51-5.32)  0.402 0.56  (0.21-1.52)  0.253
PIPd 1.10  (0.92-1.33)  0.292 1.24  (1.05-1.47)  0.012
Factors of perinatal adaption
Cord blood pHe 1.98  (0.41-9.48)  0.393 4.37  (1.4-13.61)  0.011
aPGaR score at 10 min.f 1.05  (0.74-1.49)  0.783 1.55  (1.14-2.12)  0.006
CRIB-score 0.93 (0.82-1.05)  0.232 1.14  (1.01-1.28)  0.024
Environmental risk factors
Contact to other childreng 4.71 (1.77-12.56)  0.002 1.30  (0.59-2.90)  0.516
Maternal atopy 1.52  (0.41-5.66)  0.532 0.82  (0.27-2.46)  0.727
smoking in pregnancy 1.41  (0.29-6.79)  0.672 1.58  (0.48-5.20)  0.450
In the table are shown: odds ratio (oR), calculated by univariable logistic regression, defining the increased odds of having the
respective outcome with the respective risk factor present; 95% Confidence interval (CI) and p-value. 
a BPd was defined as in the consensus guidelines (2)
b Chorioamnionitis was verified by histological findings of the placenta
c Pda = haemodynamic relevant patent ductus arteriosus
d PIP = maximum peak inspiratory pressure
e Cord blood pH = arterial chord blood pH: 1 defined as <7.15 and 0 defined as > 7.15
f comparable results were obtained for aPGaR-scores at 1 and 5 minutes 
g Contact to other children = having siblings or going to a nursery care institution regularly
5) Pramana_Umbruchvorlage  21.04.11  15:25  Seite 227conomic  status  were  associated  with  respiratory
symptoms in the first year of life in preterms born
before 29 weeks of gestation [8]. our results show
that this holds also for preterms born after 29 weeks
of gestation. In contrast, severe respiratory symptoms
were  stronger  associated  with  parameters  reflecting
perinatal adaptation. aPGaR- and CRIB score have
been described to predict outcome of preterm infants
[19] and it has been shown that higher PIP is associat-
ed with decreased survival rates [17]. 
surprisingly,  BPd  was  not  correlated  with  severe
respiratory morbidity in the present study, although a
trend was found for severe outcomes. the association
with BPd severity and long-term respiratory morbidi-
ty  has  remained  controversial  and  comparison  of
these studies is difficult due to varying BPd defini-
tions [25-28]. Ehrenkranz et al. found a reasonable as-
sociation  between  severe  outcomes  and  the  “new
BPd”  classification  [3].  one  possible  explanation
might  be  differing  neonatal  treatment  strategies  be-
tween Europe and the usa. Premature infants in our
cohort  had  shorter  mechanical  ventilation  and  early
nasal CPaP therapy. In contrast, different guidelines
lead to intubation and longer duration of mechanical
ventilation in the usa [29]. 
Gestational age was not associated with respiratory
symptoms.  these  results  are  again  different  than
american results [30] but in line with the London co-
hort  [8].  this  might  reflect  the  different  picture  of
“new” BPd, which is indeed known not to be exclu-
sively dependent on gestational age [8]. 
While risk factors for common respiratory symp-
toms were similar for premature and term neonates,
severe outcomes in preterms were related to perinatal
factors. furthermore, other factors found to be asso-
ciated with respiratory morbidity in the term-born co-
hort,  such  as  sex,  birthweight  and  maternal  atopy
were  not  associated  with  respiratory  symptoms  in
preterms. We assume that the influence of these fac-
tors is masked by stronger effects induced by prema-
turity and the related developmental changes of the
immune system as well as of lung and airway growth.
It is e.g. known that boys have smaller airways at birth
and thus more respiratory problems than girls [31],
but this gender difference is less prominent in prema-
ture infants [32] and likely to be overruled by other
factors.
PaREntaL PERCEPtIon
one third of the parents may overestimate the com-
mon respiratory morbidity of their preterm born chil-
dren  when  comparing  to  term  infants  and  consult
their Paediatrician early. thus parental counselling at
discharge related to common in respect to severe res-
piratory morbidity may help to improve the burden of
the health care system.
MEtHodoLoGICaL IssuEs
there are limitations of our study. It is a retrospective
survey, with questionnaires sent to the parents at dif-
ferent ages of their children. this may lead to recall
bias, however similar results after stratification by age
at reply of questionnaires makes this unlikely. further-
more it has been shown that questions on respiratory
symptoms have a good repeatability, supporting validi-
ty of our findings [13, 33]. another possible bias is the
fact that we only included children who underwent in-
fant lung function which makes generalisation of the
results more difficult. due to rather low numbers we
were not able to perform multivariable analyses. the
relatively small sample size might also explain why pa-
rameters like gestational age or chorioamnionitis were
only weakly associated with respiratory morbidity [3].
In addition, causal pathways are difficult to model in
the analysis, because many of the examined parame-
ters may function either as independent risk factor or
alternatively be a consequence of another risk factor,
therefore lying in the causal pathway. for instance high
peak  inspiratory  pressure  can  injure  the  premature
lung by itself, on the other hand, ventilation with high
pressures could have been made necessary because of
an injured premature lung. all these factors are impor-
tant to bear in mind when interpreting the results. to
validate our findings and clearly disentangle all these
interactions, larger studies should be conducted in fu-
ture.
RELEVanCE
from a clinical point of view, the identification of risk
factors  may  help  to  promote  further  individualized
treatment and prevent long-term sequelae in preterm
infants. the risk factors for respiratory diseases during
infancy should be considered as an important part of
planning discharge and follow-up of high-risk prema-
ture infants. for instance, in line with other, mainly
European studies, we can support the hypothesis that
gentle breathing support results in less frequent BPd
rates as well as in less respiratory symptoms even in
very young preterm infants [34].
from a public health point of view, prenatal birth is
the commencement of a relevant burden of disease
for patients, parents [35] and the health care system.
this includes doctor visits apart from routine check-
ups, re-hospitalisations as well as psychological and fi-
nancial burden of long-term medication. this burden
is strongly dependent on the correct identification of
those  infants  subject  to  appropriate  treatment.  In
switzerland, decisions on medication and reimburse-
ment of health care costs are strongly influenced by
the current BPd definition. for instance, vaccination
against respiratory syncytial virus is only recommend-
ed and paid in preterm infants with severe BPd, it can
be considered for patients with moderate BPd and is
not recommended for patients with mild BPd. How-
ever, our data and other studies show that prematurity
rather than BPd definitions and other risk factors de-
fine respiratory morbidity in these preterm infants in
the  first  year  of  life.  due  to  these  aspects  current
health care policies need urgent reconsideration.
ConCLusIon
the results of this study indicate that premature in-
fants  are  subject  to  a  high  incidence  of  respiratory
morbidity even after hospital discharge imposing a rel-
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health care system. By describing respiratory morbidi-
ty in the first year of life in these preterm infants and
assessing associated risk factors, our study will con-
tribute to the identification of patients with the high-
est  risk  for  later  respiratory  morbidity.  Growing
knowledge on the pathophysiology as well as changes
in perinatal management will however lead to continu-
ous changes of this picture. as more patients with the
“new” form of BPd will reach older age, larger stud-
ies with longer follow-up times and measurement of
subtle lung function indices will be needed to assess
the long-term outcome of these children.
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